首页|分化型甲状腺癌患者放射性131I治疗疗效的影响因素分析

分化型甲状腺癌患者放射性131I治疗疗效的影响因素分析

扫码查看
目的 分析分化型甲状腺癌(DTC)患者放射性 131I治疗疗效的影响因素.方法 选取120例DTC患者,接受甲状腺癌根治术及术后放射性 131I治疗,首次放射性 131I治疗后6个月评估疗效.DTC患者放射性 131I治疗疗效的影响因素采用多因素Logistic回归分析.结果 疗效判定结果显示,疗效良好79例,疗效不良41例,分别作为良好组和不良组.良好组与不良组患者性别、年龄、肿瘤直径、TNM分期、淋巴结转移数目、复发风险、放射性 131I治疗前甲状腺球蛋白(Tg)水平、首次放射性 131I治疗剂量比较,差异均有统计学意义(P﹤0.05).多因素Logistic回归分析结果显示,肿瘤直径﹥4 cm、淋巴结转移数目≥5、放射性 131I治疗前Tg水平升高均是DTC患者放射性 131I治疗疗效的独立危险因素(P﹤0.05),首次放射性 131I治疗剂量高是DTC患者放射性 131I治疗疗效的保护因素(P﹤0.05).结论 肿瘤直径﹥4 cm、淋巴结转移数目≥5、放射性 131I治疗前Tg水平升高均是DTC患者放射性 131I治疗疗效的独立危险因素,首次放射性 131I治疗剂量高是保护因素.
Analysis of influencing factors on the efficacy of radioactive 131 I therapy in patients with differentiated thyroid carcinoma
Objective To analyze the influencing factors of the efficacy of radioactive 131I therapy in patients with dif-ferentiated thyroid carcinoma(DTC).Method A total of 120 patients with DTC were selected and received radical sur-gery for thyroid cancer and postoperative radioactive 131I treatment.The efficacy was evaluated 6 months after the first ra-dioactive 131I treatment.The multivariate Logistic regression was used to analyze the influencing factors of the efficacy of radioactive 131I treatment in DTC patients.Result The efficacy evaluation results showed that 79 cases had good efficacy and 41 cases had poor efficacy,which were respectively classified as the good group and the poor group.There were sta-tistically significant differences in gender,age,tumor diameter,TNM stage,number of lymph node metastases,recurrence risk,the level of thyroglobulin(Tg)before radioactive 131I treatment,and first dose of radioactive 131I treatment between the good group and poor group(P<0.05).Multivariate Logistic regression analysis showed that tumor diameter>4 cm,number of lymph node metastases≥5,and high level of Tg before radioactive 131I treatment were independent risk factors for the efficacy of radioactive 131I treatment in DTC patients(P<0.05),high first dose of radioactive 131I treatment was a protective factor for the efficacy of radioactive 131I treatment in DTC patients(P<0.05).Conclusion Tumor diameter>4 cm,number of lymph node metastases≥5,and high level of Tg before radioactive 131I treatment are independent risk fac-tors for the efficacy of radioactive 131I treatment in DTC patients,and high first dose of radioactive 131I treatment is a pro-tective factor.

radioactive 131I treatmentdifferentiated thyroid carcinomaefficacyinfluencing factor

伊莎莎、曹晓征、臧志娜

展开 >

河南科技大学第一附属医院核医学科,河南 洛阳 471000

放射性131I治疗 分化型甲状腺癌 疗效 影响因素

2024

癌症进展
中国医学科学院,北京协和医学院

癌症进展

影响因子:1.004
ISSN:1672-1535
年,卷(期):2024.22(22)